- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02903264
Gestational Diabetes Mellitus, Obesity and Periodontal Disease
September 12, 2016 updated by: Carla Andreotti Damante, University of Sao Paulo
Gestational Diabetes Mellitus, Obesity and Periodontal Disease: a Cross Sectional Study
This study evaluated the periodontal condition of gestational diabetes mellitus (GDM) patients and a healthy non-pregnant control group.
For the GDM group all medical data were recorded, including obesity/insulin resistance indicators.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Gestational diabetes mellitus is associated to a worse periodontal condition.
Many patients with these two diseases are also obese.
After delivery, some patients maintain the pre-pregnancy obesity status and this condition is also associated to periodontal disease.
The mechanisms involved in the relationship of all these medical and periodontal conditions are not clear.
Study Type
Observational
Enrollment (Actual)
67
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sao Paulo
-
Bauru, Sao Paulo, Brazil, 17012-901
- Bauru School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 42 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Only female participants
Description
Inclusion Criteria:
- Inclusion criteria for GDM group was pregnant women with diagnosis of GDM based on glucose determination described in a previous study (19) and under medical treatment of an endocrinologist and the presence of at least one tooth per sextant.
- Inclusion criteria for control group were absence of periodontal disease, mean age similar to test group and presence of at least one tooth per sextant.
Exclusion Criteria:
- The exclusion criteria for GDM group were pregnant women without diagnosis of diabetes, age below 18 years or higher than 42 years, and the presence of other systemic diseases.
- In control group, women were excluded if they were pregnant, had diabetes or other systemic disease and age below 18 years or higher than 42 years.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
GDM group
Gestational diabetes mellitus patients under treatment of an endocrinologist
|
|
|
Control
Healthy non-pregnant females
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Periodontal disease (gingivitis and periodontitis) measured by a periodontal probe and classified according to severity
Time Frame: One day
|
Severe periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with CAL ≥ 6mm and ≥1 interproximal site with PPD ≥5mm.
Moderate periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with CAL ≥ 4mm or ≥ 2 interproximal sites in different teeth with PPD ≥5mm.
Mild periodontitis was defined as ≥ 2 interproximal sites in different teeth with ≥ 3 mm CAL and ≥ 2 interproximal sites in different teeth with ≥ 4 mm PPD or at least 1 site with PPD ≥ 5 mm (20,21).
Gingivitis was determined as follows: Subjects were considered healthy if presented PPD ≤3mm/BOP extent scores < 10% and with gingivitis if presented PPD ≤3mm/ BOP extent scores >10%.
Prevalence of periodontal disease was the sum of gingivitis, mild, moderate and severe periodontitis.
|
One day
|
|
Obesity measured by a tape and a scale
Time Frame: one day
|
Obese if: body mass index - BMI ≥ 25 Kg/m2 (weight in kilograms, height in meters) Obese if : waist-to-hip ratio - WHR >0.85 (cm)
|
one day
|
|
Gestational diabetes mellitus diagnosed by an endocrinologist
Time Frame: one day
|
Diagnosis stablished by a doctor based on glucose determination.
The data was registered in the patient's medical chart.
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyslipidemia as an indicator of obesity/insulin resistance
Time Frame: one day
|
The data was registered in the patient's medical chart.
Dyslipidemia = HDL ≤ 35 mg/dL / LDL≥ 100 mg/dL / Total cholesterol ≥200 mg/dL / Triglycerides ≥ 150 mg/dL / VLDL < 30 mg/dL
|
one day
|
|
Leukocytosis as an indicator of inflammation
Time Frame: one day
|
The data was registered in the patient's medical chart. ≥ 10.000/L |
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carla Damante, PhD, University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
September 6, 2016
First Submitted That Met QC Criteria
September 12, 2016
First Posted (Estimate)
September 16, 2016
Study Record Updates
Last Update Posted (Estimate)
September 16, 2016
Last Update Submitted That Met QC Criteria
September 12, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BauruSchoolDentistry
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Gestational diabetes mellitus
-
Wolfson Medical CenterNot yet recruitingPolyhydramnios
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Hospices Civils de LyonCompletedOral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)Gestational DiabetesFrance
-
Centre Hospitalier René DubosCompleted
-
Singapore Institute for Clinical SciencesNational University Polyclinics, Singapore; National University of SingaporeCompletedHealthy | Diabetes, Gestational | Gestational Diabetes Mellitus in PregnancySingapore
-
University of FloridaTerminatedGestational Diabetes Mellitus in PregnancyUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterChildren's Hospital of Fudan UniversityRecruiting
-
Hacettepe UniversityRecruitingDiabetes MellitusTurkey
-
Koç UniversityCompletedDiabetes Mellitus, GestationalTurkey
-
Esa M Davis, MD MPH FAAFPEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedGlucose Intolerance | Pregnancy | Gestational DiabetesUnited States